The Neuroprotective Effect of a Synthetic Chalcone Analog Through the Activation of Akt/Erk/Nrf2 Signaling

Yuting Cui,Yue Xiong,Hua Li,Mengqi Zeng,Yuan Li,Weiqiang Lv,Ruijun Cao,Zhihui Feng,Jiankang Liu
DOI: https://doi.org/10.2139/ssrn.3448004
2019-01-01
SSRN Electronic Journal
Abstract:Background: Phase II enzymes are antioxidative enzymes that are regulated by the key transcription factor Nrf2, and activated Nrf2 has been considered beneficial for neuronal protection. Methods: We synthesized a novel synthetic chalcone analog, 1-(2,3,4-trimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-acrylketone (Tak), and evaluated its hippocampal neuronal protection in both in vitro glutamate toxicity model and in vivo high fat-diet (HFD) associated neuronal disorders.Findings: We found that treatment with Tak has no significant toxicity on cultured neuronal cells. Instead, Tak increases cellular ATP production by increasing mitochondrial function and decreases ROS levels by increasing phase II enzyme expression. Tak pretreatment prevents glutamate-induced excitotoxic neuronal death accompanied by suppressed mitochondrial respiration, increased superoxide production, and activation of apoptosis. Further investigation showed that the protective effect of Tak is mediated by the Akt/Erk signaling pathway. In addition, an energy stress animal model showed that HFD induces metabolic disorders in mice and suppresses Akt/Erk signaling and mitochondrial activity in the hippocampus. Administration of Tak had no significant effects on the mouse metabolic status but sufficiently increased Akt/Erk signaling-mediated antioxidative enzyme expression and prevented hippocampal neuronal apoptosis.Interpretation: Our study demonstrated that Tak exerts neuronal protection via Akt/Erk signaling in vivo and in vitro, suggesting a promising pharmacological candidate for the treatment of neuronal diseases.Funding Statement: This work was supported by the National Basic Research Program (2015CB553602), the National Natural Science Foundation of China (81571050, 31770917, 31570777, 91649106, and 31701025), the General Financial Grant from the China Postdoctoral Science Foundation (2017M613108) and the Fundamental Research Funds for the Central Universities (Z201806073).Declaration of Interests: The authors declare no competing financial interests.Ethics Approval Statement: Animal procedures were approved by the Xi’an Jiaotong University Animal Care and Use Committee.
What problem does this paper attempt to address?